Comments on: Blackstone Unveils Immunology Startup With $300M and a Phase 2-Ready Drug From Merck

Comments on: Blackstone Unveils Immunology Startup With $300M and a Phase 2-Ready Drug From Merck https://medcitynews.com/2024/05/blackstone-life-sciences-immunology-inflammation-asthma-copd-startup-uniquity/ Healthcare technology news, life science current events Wed, 15 May 2024 20:51:10 +0000 hourly 1 https://wordpress.org/?v=6.5.3